Towards Rational Prescription of Common Inhaler Medication in the Multimorbid COPD Patient

Ioanna Tsiligianni*, Kristian Jong Hoeines, Christian Jensen, Janwillem W. H. Kocks, Bjorn Stallberg, Claudia Vicente, Rudi Peche

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Downloads (Pure)

Abstract

COPD is a chronic disease, typically accompanied by multiple comorbid conditions. The need to apply several, and sometimes conflicting, disease-specific treatment guidelines, complicates the management of individual patients. Moreover, national and international recommendations evolve rapidly but provide limited guidance on the integrated approach in the multimorbid patient. Particularly bothersome is the fact that the presence of comorbidities may deteriorate the course of COPD, and inversely COPD may affect the outcome of the comorbid diseases. In addition, some effects of commonly prescribed COPD inhaler medications, including beta2-agonists, long-acting antimuscarinics and especially inhaled corticosteroids, mimic or worsen COPD-related comorbidities. Therefore, the authors combined their perspectives to formulate advice that may help physicians to improve COPD patient care in daily practice when comorbidities are present. Diabetes, atrial fibrillation, osteoporosis/fractures, infections (pneumonia and tuberculosis) and asthma were identified as areas where practicing clinicians should give special attention to the risk-benefit ratio of the inhaled medication. Overall, the presence of multimorbidity in a COPD patient should act as a signal to carefully reconsider the treatment choices.

Original languageEnglish
Pages (from-to)1315-1327
Number of pages13
JournalInternational Journal of Chronic Obstructive Pulmonary Disease
Volume16
DOIs
Publication statusPublished - 11-May-2021

Keywords

  • comorbidity
  • multimorbidity
  • polypharmacy
  • inhaler medication
  • OBSTRUCTIVE PULMONARY-DISEASE
  • PRIMARY-CARE
  • CLINICAL PHENOTYPES
  • RISK
  • COMORBIDITIES
  • CORTICOSTEROIDS
  • EXACERBATIONS
  • PREVALENCE
  • MANAGEMENT
  • ASTHMA

Cite this